This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on September 06, 2022 and assigned serial number 91278405 by the TTAB.

Plaintiff:
ViiV Healthcare Company represented by PAUL C. LLEWELLYN of ARNOLD & PORTER KAYE SCHOLER LLP.
Trademark Information: EPIVIR-HBV – US Trademark Serial Number 75497099
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Global Biolife, Inc. represented by MARI-ELISE PAUL of STITES & HARBISON PLLC.
Trademark Information: EQUIVIR – US Trademark Serial Number 97280929
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
September 06, 2022 – FILED AND FEE
September 06, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
September 06, 2022 – INSTITUTED
October 17, 2022 – ANSWER
December 14, 2022 – P MOT FOR EXT W/ CONSENT
December 14, 2022 – EXTENSION OF TIME GRANTED
February 13, 2023 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
February 13, 2023 – SUSPENDED
April 12, 2023 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
April 12, 2023 – SUSPENDED
June 07, 2023 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
June 07, 2023 – SUSPENDED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.